Dipòsit Digital de la Universitat de Barcelona
metadata only
CC BY-NC-ND 3.0
IGF2 is up-regulated by epigenetic mechanisms in Hepatocellular Carcinoma and is an actionable oncogene product in experimental models
BACKGROUND & AIMS: Effective treatments are urgently needed for hepatocellular carcinoma (HCC), which is usually diagnosed at advanced stages. Signaling via the insulin-like growth factor (IGF) pathway is aberrantly activated in HCC by IGF2 overexpression. We aimed to elucidate the mechanism of
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- AKR1C3-PKM2-oxidative phosphorylation axis drives prostate cancer radioresistance via UBE2T upregulation.#174570
- INVESTIGATING THE ROLE OF INNATE LYMPHOID CELLS AND Tc17 IN HUMAN HEPATOCELLULAR CARCINOMA#258473
- Harnessing the ubiquitin-proteasome system: advances and challenges of PROTACs in breast cancer.#1379955
- CD73 promotes the maturation of murine NK cells and their survival in the tumor microenvironment#336260
- Tumor-induced lipid loss physically accelerates breast cancer invasion into mammary adipose tissue#1048973
Record · ID 1422269
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive